Kevin P. Kerns

Array ( [id] => 8484001 [patent_doc_number] => 20120283408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'FUSION PROTEIN BINDING SPECIFICALLY TO CONSTANT REGION OF ANTIBODY, METHOD OF PREPARING THE FUSION PROTEIN, AND METHOD OF ISOLATING ANTIBODY USING THE FUSION PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/508002 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4763 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8981591 [patent_doc_number] => 08512704 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Tmem27 antibody' [patent_app_type] => utility [patent_app_number] => 13/388974 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 21 [patent_no_of_words] => 6170 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026726 [patent_doc_number] => 08536308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Antibodies to interleukin-6' [patent_app_type] => utility [patent_app_number] => 12/834546 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10924 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12834546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8163353 [patent_doc_number] => 08173117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Mouse CX3C chemokine polypeptides' [patent_app_type] => utility [patent_app_number] => 12/833069 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23170 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173117.pdf [firstpage_image] =>[orig_patent_app_number] => 12833069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158466 [patent_doc_number] => 20120100155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'PHARMACEUTICAL AGENT' [patent_app_type] => utility [patent_app_number] => 13/379996 [patent_app_country] => US [patent_app_date] => 2010-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4714 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100155.pdf [firstpage_image] =>[orig_patent_app_number] => 13379996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251891 [patent_doc_number] => 20120156214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'SOLUBLE LYMPHOTOXIN-BETA RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES' [patent_app_type] => utility [patent_app_number] => 12/813029 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18485 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156214.pdf [firstpage_image] =>[orig_patent_app_number] => 12813029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10887965 [patent_doc_number] => 08911960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Method for identifying idiopathic pneumonia progression by measuring the level of mannose-binding protein C' [patent_app_type] => utility [patent_app_number] => 13/375523 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17531 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8278430 [patent_doc_number] => 20120172310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Soluble Guanylyl Cyclase a1 and a-8r Peptide as Diagnostic Markers of and Therapeutic Targets for Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 13/375307 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 17461 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391971 [patent_doc_number] => 20100303815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra' [patent_app_type] => utility [patent_app_number] => 12/790626 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14636 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 62 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303815.pdf [firstpage_image] =>[orig_patent_app_number] => 12790626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277381 [patent_doc_number] => 20120171253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Fibromodulin Peptide' [patent_app_type] => utility [patent_app_number] => 13/322124 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13030 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146499 [patent_doc_number] => 08163503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Methods of identifying compounds that bind TANGO509' [patent_app_type] => utility [patent_app_number] => 12/800681 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 76050 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163503.pdf [firstpage_image] =>[orig_patent_app_number] => 12800681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7996801 [patent_doc_number] => 08080248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-20 [patent_title] => 'Method of treating rheumatoid arthritis with an IL-6R antibody' [patent_app_type] => utility [patent_app_number] => 12/780006 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20529 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/080/08080248.pdf [firstpage_image] =>[orig_patent_app_number] => 12780006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7518711 [patent_doc_number] => 07972812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-05 [patent_title] => 'DNA encoding a soluble fragment of TRAIL polypeptide' [patent_app_type] => utility [patent_app_number] => 12/779662 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23837 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/972/07972812.pdf [firstpage_image] =>[orig_patent_app_number] => 12779662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932421 [patent_doc_number] => 08492119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Antibody to human IL-3 receptor alpha chain' [patent_app_type] => utility [patent_app_number] => 13/266603 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33934 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13266603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7965393 [patent_doc_number] => 07939297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Mammalian cytokines; related reagents and methods' [patent_app_type] => utility [patent_app_number] => 12/764809 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28628 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939297.pdf [firstpage_image] =>[orig_patent_app_number] => 12764809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016542 [patent_doc_number] => 20110224153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/762532 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 25848 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224153.pdf [firstpage_image] =>[orig_patent_app_number] => 12762532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6168310 [patent_doc_number] => 20110196128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'MURINE ZCYTOR17 LIGAND POLYNUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/756959 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80506 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20110196128.pdf [firstpage_image] =>[orig_patent_app_number] => 12756959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401460 [patent_doc_number] => 08691512 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Method for the detection of sepsis by determining peptide prohormone levels' [patent_app_type] => utility [patent_app_number] => 12/756235 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5340 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017133 [patent_doc_number] => 20110224406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'INTERLEUKIN-9 RECEPTOR MUTANTS' [patent_app_type] => utility [patent_app_number] => 12/752219 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14814 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224406.pdf [firstpage_image] =>[orig_patent_app_number] => 12752219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540560 [patent_doc_number] => 08058403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Antibodies to stromal cell-derived factor-1 polypeptides' [patent_app_type] => utility [patent_app_number] => 12/752936 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 33382 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058403.pdf [firstpage_image] =>[orig_patent_app_number] => 12752936 [rel_patent_id] =>[rel_patent_doc_number] =>)